Daily non-political popular news in brief.

Cell death suppression increases efficacy of M2 vaccines

Scientists from Cure Lab, Inc. in collaboration with Boston University School of Medicine published new findings indicating that unmodified M2 may have a negative effect on anti-influenza vaccination. The researchers also demonstrated how this detrimental effect of M2 can be eliminated, thereby allowing any future M2-containing vaccine to be both broadly protective as well as safe. This study appears in the Jan. 16 issue of the online journal PLoS ONE.

Read more »

Keywords: cell, death, suppression, efficacy, vaccines, vaccine

« Previous | Next »

Similar news on "Cell death suppression increases efficacy of M2 vaccines":

1. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
2. Pancreatic cancer vaccine halts progression of disease in some patients
   04-17-2007 · EurekAlert!
   A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
   Similar news · Read more »
   
3. Tumor cells evade death through autophagy
   01-18-2007 · EurekAlert!
   Autophagy (a process that enables cells to turnover their contents) is initiated in tumor cells by chemotherapy and radiation, but it is not known if this causes tumor cell death or helps tumor cells survive. A new mouse study now indicates that autophagy is a survival mechanism for tumor cells treated with agents that initiate tumor cell death, suggesting that adjunct treatment with autophagy inhibitors might increase the efficacy of some chemotherapeutics in cancer patients.
   Similar news · Read more »
   
4. Combination vaccines okay for infants, study shows
   10-03-2007 · EurekAlert!
   Good news for new parents -- a University of Rochester recently published in the Journal of Pediatrics shows that no efficacy or safety is compromised when clinicians administer a new combination vaccine that streamlines the newborn immunization schedule. By tripling up three of the recommended shots, pediatricians can reduce the painful "poke" total, from five to three, at each of the infant's three bimonthly checkups.
   Similar news · Read more »
   
5. International studies show high efficacy for HPV vaccine
   05-31-2007 · EurekAlert!
   A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancerÑstrains 16 and 18. Researchers combined and analyzed the data from four randomized trials that involved 20,583 women ages 15 to 26 from more than two dozen countries. Researchers found that the prophylactic administration of the vaccine was highly effective in preventing pre-malignant changes of the cervix.
   Similar news · Read more »
   
6. Painkillers may threaten power of vaccines
   11-28-2006 · EurekAlert!
   With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.
   Similar news · Read more »
   
7. "Combination" Lyme Disease Vaccine Proteins Patented
   04-09-2007 · Brookhaven National Laboratory
   Scientists at Brookhaven Lab and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.
   Similar news · Read more »
   
8. New target for HIV/AIDS drugs and vaccine discovered
   07-26-2007 · EurekAlert!
   Researchers from Rome, Italy, describe a finding in the August 2007 print issue of the FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the body's innate immune system.
   Similar news · Read more »
   
9. Key to acute lung injury lies in Ang2 protein
   11-10-2006 · EurekAlert!
   Acute lung injury caused by cell death, high and potentially toxic concentrations of oxygen (hyperoxia), and the resulting excess fluid in the lungs (pulmonary edema), may be controlled by modulating levels of the angiopoietin2 (Ang2) protein, researchers at Yale School of Medicine report in the November 5 online issue of Nature Medicine.
   Similar news · Read more »
   
10. Common anesthetic may induce cell death, generation of Alzheimer's-associated protein
    02-06-2007 · EurekAlert!
    A new study has found how one of the most commonly used anesthetics may produce Alzheimer's-like changes in the brain. Researchers from Massachusetts General Hospital and colleagues describe the mechanism by which the anesthetic isoflurane may induce both the cell-death process known as apoptosis and the generation of amyloid-beta protein in cultured neural cells.
    Similar news · Read more »